Becton, Dickinson and Company Pre-Tax Income decreased by 90.1% to $39.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 80.6%, from $201.00M to $39.00M. Over 4 years (FY 2021 to FY 2025), Pre-Tax Income shows relatively stable performance with a 0.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
This provides a view of profitability that is not skewed by varying tax rates or one-time tax credits.
A company's profits before the deduction of corporate income tax. It combines operating performance with non-operating f...
Used to compare companies across different tax jurisdictions to see who generates more raw profit.
income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $378.00M | $0.00 | $600.00M | $442.00M | $421.00M | $320.00M | $481.00M | $529.00M | $471.00M | $181.00M | $359.00M | $633.00M | $500.00M | $513.00M | $306.00M | $201.00M | $703.00M | $671.00M | $393.00M | $39.00M |
| QoQ Change | — | -100.0% | — | -26.3% | -4.8% | -24.0% | +50.3% | +10.0% | -11.0% | -61.6% | +98.3% | +76.3% | -21.0% | +2.6% | -40.4% | -34.3% | +249.8% | -4.6% | -41.4% | -90.1% |
| YoY Change | — | — | — | — | +11.4% | — | -19.8% | +19.7% | +11.9% | -43.4% | -25.4% | +19.7% | +6.2% | +183.4% | -14.8% | -68.2% | +40.6% | +30.8% | +28.4% | -80.6% |
| Segment | Q2 '21 | Q3 '21 |
|---|---|---|
| Medical | $514.00M | $647.00M |
| Life Sciences | $514.00M | $439.00M |
| Interventional | $514.00M | $208.00M |
| Total | $378.00M | $0.00 |
Interventional, Life Sciences, Medical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.